- Home
- DCTH vs ESEA Comparison
DCTH vs ESEA Comparison
Compare DCTH & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCTH | ESEA |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.7M | 432.9M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | DCTH | ESEA |
|---|---|---|
| Price | $10.12 | $53.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $22.60 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 682.8K | 36.2K |
| Earning Date | 11-04-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 5.18% |
| EPS Growth | N/A | ★ 6.77 |
| EPS | 0.03 | ★ 17.38 |
| Revenue | $79,603,000.00 | ★ $223,794,428.00 |
| Revenue This Year | $131.97 | $10.05 |
| Revenue Next Year | $38.84 | N/A |
| P/E Ratio | $291.54 | ★ $3.11 |
| Revenue Growth | ★ 251.54 | 7.26 |
| 52 Week Low | $8.12 | $26.30 |
| 52 Week High | $18.23 | $66.00 |
Technical Indicators
Market Signals| Indicator | DCTH | ESEA |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 36.38 |
| Support Level | $9.84 | $54.90 |
| Resistance Level | $10.28 | $58.90 |
| Average True Range (ATR) | 0.45 | 2.53 |
| MACD | 0.04 | -0.75 |
| Stochastic Oscillator | 57.50 | 11.85 |
Price Performance
Historical ComparisonAbout DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.